NumberOfSamples: Forty-five human CSF specimens  
BiologicalReplicate: 16 patients  
Organism: human  
Specimen: human CSF specimens  
CellLine: WM164  
CellLine: 451Lu  
CellLine: WM983A  
CellLine: A375  
Depletion: Pierce Top 12 Abundant Protein Depletion Spin Columns  
CleavageAgent: trypsin  
Label: TMT-6plex reagents  
FractionationMethod: basic pH RPLC fractionation  
NumberOfFractions: final 24 concatenated fractions  
AssayName: LC-MS/MS  
GradientTime: 90 minute gradient  
Instrument: RSLC nano  
Instrument: QExactive Plus mass spectrometer  
SupplementaryFile: Supplemental Table 1  
PooledSample: identical reference pool  
SupplementaryFile: PXD016002 and 10.6019/PXD016002  
Treatment: 3μM vemurafenib  
SampleTreatment: a 1:1 mixture of serum-free media:CSF from patient 1, patient 2 or patient 3  
Time: 8 hours  
ConcentrationOfCompound: 100 ng of RNA  
Instrument: Illumina NextSeq 500 v2 sequencer  
Time: 72 hours  
Staining: Annexin-V and TMRM  
AssayName: Proteome Profiler Human Phospho-Kinase Array Kit  
Instrument: Ventana Discovery XT automated system  
Instrument: Aperio AT2 slide scanner  
AssayName: TGF-β1 ELISA Kit  
FactorValue: 1 × 10^4 cells/well  
Treatment: exogenous TGF-β1  
Time: 2 weeks